Arnatar Therapeutics
San Diego
About Arnatar Therapeutics
Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $66.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2024)
- Website: arnatar.com
- Phone: +1 858 757 7299
Industries & Categories
Biopharma, Medical
Canonical: https://fsome.com/organization/arnatar-therapeutics-29754 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.